相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/5 | － | 2025/6/6 | 2025/6/6 | 差异化分红送转： 否 证券代码：603786 证券简称：科博达 公告编号：2025-029 科博达技术股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利0.65元 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经科博达技术股份有限公司（以下简称"公司"）2025 年 5 月 16 日的 2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本4 ...

Overview - The rapid development of the automotive market in China has significantly increased the demand for air suspension systems, driven by consumer preferences for comfort, safety, and performance [1][10] - The air suspension system market is projected to reach a demand of 1.0643 million sets and a market size of 10.737 billion yuan in 2024, with over 60% of the demand coming from the passenger vehicle sector [1][10] Industry Policies - The Chinese government has issued various policies to support the development of the automotive parts industry, including air suspension systems, creating a favorable policy environment for industry growth [4][5] Industry Chain - The air suspension system industry consists of upstream suppliers of raw materials (steel, plastic), component suppliers (air springs, dampers, ECU, sensors), system assemblers in the midstream, and downstream automotive manufacturers and aftermarket services [7][8] Market Demand - The automotive market in China has shown steady growth, with production and sales of vehicles increasing by 14.5% and 11.2% year-on-year in early 2025, respectively, and a notable 50.4% increase in the production of new energy vehicles [8][10] Competitive Landscape - The air suspension system market in China is characterized by an oligopolistic structure, with the top five companies holding over 90% market share. The top three companies (Konghui Technology, Top Group, and Baolong Technology) account for 86.7% of the market [12][14] - Konghui Technology leads the market with an installation volume of 335,470 sets, capturing 41.3% of the market share, followed by Top Group with 25.8% and Baolong Technology with 19.6% [12][14] Company Profiles - Konghui Technology is the first domestic company to achieve OEM mass production of passenger car air suspension systems, supplying over 20 models and expecting to deliver over 600,000 units in 2024 [14] - Top Group specializes in automotive parts, with projected revenues of 26.6 billion yuan in 2024, where air suspension systems are a significant part of their product offerings [17] Development Trends - Future air suspension systems are expected to integrate deeply with intelligent driving systems, allowing for automatic adjustments based on road conditions to enhance ride comfort and vehicle stability [19] - The use of high-strength, lightweight materials such as aluminum and carbon fiber is anticipated to increase in air suspension systems to improve efficiency and performance while maintaining strength [19]

Market Overview - The A-share market showed weakness today, with the Shanghai Composite Index closing down by 0.18% and a total trading volume of 1.02 trillion yuan. Over 2,600 stocks rose while 2,576 fell, with 95 stocks hitting the daily limit up and 5 hitting the limit down [1]. Sector Performance - The agricultural chemical sector saw significant gains in the afternoon, with Zhongqi Co. hitting the daily limit up. Other stocks like Zhongnong United, Guangxin Co., and Lier Chemical also reached the limit up [1]. - Consumer goods stocks performed strongly throughout the day, particularly in the beverage manufacturing and clothing sectors, which had the highest gains [1]. Historical Highs - A total of 23 stocks reached historical closing highs today, with a concentration in the machinery equipment, pharmaceutical biology, and food and beverage sectors, featuring 6, 5, and 2 stocks respectively [2]. - The average increase for stocks that reached historical highs was 6.98%, with notable gainers including Hahai Huadong, Jinlongyu, and Jinghua Laser [2]. Institutional Activity - In the institutional trading board, 10 stocks saw net purchases from institutions, with Xinghui Co. leading at a net buy of 34.13 million yuan, followed by Qingdao Jinwang at 26.84 million yuan [5]. - Conversely, stocks like Xindadi and Nuofeng experienced net sales exceeding 40 million yuan [4]. Northbound Capital - Northbound capital saw net purchases in stocks like Greebo and Fenghuo Electronics exceeding 20 million yuan, while net sales over 20 million yuan were recorded for Baili Electric and San Sheng Guo Jian [6]. Corporate Announcements - Sichuan Road and Bridge is planning to acquire 100% equity of Chengdu Xinzhu Transportation Technology Co. from its controlling shareholder, which is expected to constitute a related party transaction [7]. - Muyuansheng has submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange [7]. - Keke Technology plans to repurchase shares for an employee stock ownership plan, with a budget of 10 to 20 million yuan [7]. - Zhizhi Co. announced a commitment from its controlling shareholder to not reduce their holdings from May 30 to December 31, 2025 [8].

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

证券代码：603786 证券简称：科博达 公告编号：2025-028 科博达技术股份有限公司 关于全资子公司收购捷克 IMI 公司 100%股权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 为加快推进公司全球化战略，完善公司全球生产工厂布局，提高公司可持续 发展能力，公司全资子公司德国科博达拟收购捷克 IMI 公司 100%股权，现将有 关情况公告如下： Coöpratief IMI Europe U.A. 截至 2024 年 12 月 31 日，Coöpratief IMI Europe U.A.资产总额 13,376.29 万 欧元，净资产 112.82 万欧元；2024 年度营业收入 876.80 万欧元，净利润 676.46 1 科博达技术股份有限公司（以下简称"公司"或"科博达"）全资子公司 KEBODA Deutschland GmbH & Co. KG（以下简称"德国科博达"）拟以自 有资金收购 Integrated Micro-Electronics Czech Republic ...

证券代码：603786 证券简称：科博达 公告编号：2025-027 科博达技术股份有限公司 第三届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 科博达技术股份有限公司（以下简称"公司"）第三届监事会第十四次会议通 知于 2025 年 5 月 22 日以邮件方式发出，并于 2025 年 5 月 27 日上午 11:00 时以 通讯表决方式召开。会议应出席监事 3 名，实际出席监事 3 名，会议由监事会主 席吴弘先生主持。本次会议的召集、召开程序符合《中华人民共和国公司法》及 《公司章程》等有关规定，会议合法有效。 二、监事会会议审议情况 （一）审议通过了《关于全资子公司收购捷克 IMI 公司 100%股权的议案》 监事会认为：本次收购有利于提升公司未来发展潜力，增强综合竞争力，尤 其是国际化能力；同时也有助于促进公司长期稳定发展，符合公司发展战略。本 次交易不会对公司财务状况和经营情况产生重大不利影响，不存在损害上市公司 及中小股东利益的情形。 详见同日披露的《科博达 ...

证券代码：603786 证券简称：科博达 公告编号：2025-026 科博达技术股份有限公司 第三届董事会第十五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 （一）审议通过了《关于全资子公司收购捷克 IMI 公司 100%股权的议案》 董事会认为，本次收购能够尽快实现科博达境外设厂目标，完善公司全球生 产基地布局，推动公司全球化战略落地，增强公司可持续发展能力。本次交易的 资金来源为自有资金，不会对公司财务状况和经营情况产生重大不利影响，不存 在损害上市公司及中小股东利益的情形。同意全资子公司德国科博达收购捷克 IMI 公司 100%股权。 详见同日披露的《科博达技术股份有限公司关于全资子公司收购捷克 IMI 公司 100%股权的公告》（公告编号：2025-028）。 表决结果：9 票赞成；0 票反对；0 票弃权。 特此公告。 科博达技术股份有限公司董事会 1 2025 年 5 月 28 日 2 科博达技术股份有限公司（以下简称"公司"）第三届董事会第十五次会议于 2025 年 ...

科博达（603786）公告，全资子公司德国科博达拟以自有资金收购捷克IMI公司100%股权，收购总价预 计942.56万欧元，最终交易金额以实际交割时确认为准。交易完成后，捷克IMI公司将成为公司全资孙 公司。本次收购不构成关联交易，也不构成重大资产重组，预计不存在重大法律障碍。交易自愿提交第 三届董事会第十五次会议审议，无需提交股东大会审议。 ...

Group 1 - The company, Keboda Technology Co., Ltd., will hold an annual performance briefing for 2024 and the first quarter of 2025 on May 30, 2025, from 13:00 to 14:45 [1][2] - The meeting will be conducted via video and online interaction at the Shanghai Stock Exchange Roadshow Center [2][3] - Key participants include the Chairman and President, the Secretary of the Board, the Financial Officer, the Chief Technical Expert, and an Independent Director [2] Group 2 - Investors can submit questions from May 23 to May 29, 2025, through the Shanghai Stock Exchange Roadshow Center or via the company's email [3] - The company will address common investor concerns during the briefing [2][3] - After the meeting, investors can access the main content and details of the briefing on the Shanghai Stock Exchange Roadshow Center [3]